← Evidence map

RetractedArticleEvidence-based complementary and alternative medicine : eCAM2021

Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with Cetuximab and Simvastatin in the Treatment of K-RAS Mutant Colorectal Cancer.

Guodong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34557254